Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972481-25-000130
Filing Date
2025-06-30
Accepted
2025-06-30 16:28:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2964
  Complete submission text file 0001972481-25-000130.txt   4489
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Moreadith Randall (Reporting) CIK: 0001301120 (see all company filings)

Type: 144

Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Subject) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38519 | Film No.: 251092452
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)